Adjunct Professor of Medicine, Stanford University; Distinguished Professor of Medicine Emeritus, David Geffen School of Medicine at UCLA
LOS ANGELES, CA, United States
I am the recently retired Director of the Division of Rheumatology at Cedars-Sinai Medical Center. My academic and research interests for the past 40 years have centered on the genetic and environmental risks for outcome in chronic rheumatic diseases. My experiences over the decades included organization and implementation of large-scale outcome studies and clinical trials funded by industry, the NIH, the Veterans Administration, and multiple Foundations. These include experience as an investigator for National Institutes of Health sponsored outcome and clinical trial studies in systemic lupus erythematosus, osteoarthritis, ankylosing spondylitis, vasculitis, scleroderma, sudden sensory-neural hearing loss, and rheumatoid arthritis. Board certified in internal medicine and rheumatology, I have participated on agencies, review panels and advisory boards for numerous healthcare organizations, including the FDA Arthritis Advisory Committee, Veterans Administration Cooperative Studies Program, National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National Heart, Lung, and Blood Institute (NHLBI), Medical Board of California, Arthritis Foundation, American College of Rheumatology, Institute of Medicine (National Academy of Sciences) and National Board of Medical Examiners. My own work has been published in more than 475 peer-reviewed journals and I have edited 12 books in the field of Rheumatic Diseases
Disclosure information not submitted.
Monday, November 14, 2022
4:30 PM – 5:30 PM Eastern Time
